Maravai LifeSciences Holdings MRVI 深 沪
等待开盘 09-13 09:30:00 美东时间
2.67
-0.120
-4.30%
华盛通- 最 高2.7945
- 今 开2.78
- 成交量 120.29万股
- 最 低 2.64
- 昨 收 2.79
- 总市值 3.87亿
- 52周最高 8.60
- 市盈率 静 --
- 换手率 0.83%
- 52周最低 1.665
- 委 比 48.97%
- 总股本 1.45亿
- 历史最高 63.55
- 量 比 0.99
- 振 幅 5.54%
- 历史最低 1.665
- 每 手 1
- 风险率 2.19%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股牛股 | 多只绩优股狂飙！Rumbleon涨超60%，Tonix制药控股涨超32%
多只绩优股狂飙！Rumbleon涨超60%，Tonix制药控股涨超32%；美国7月机票价格创3年多来最大月度涨幅！美国航空股Frontier Group涨近30%>>
08-13 15:56
8月13日隔夜要闻：美股收高 中概普涨 OPEC收紧供需预期 波音7月飞机交付量下降两成 美CPI数据强化降息预期
欲览更多环球财经资讯，请移步7×24小时实时财经新闻 市场 收盘：纳指与标普500再创新高 CPI数据强化降息预期 8月12日美股成交额前20：马斯克威胁要...
08-13 06:30
Maravai生命科学宣布削减成本计划
Maravai生命科学公司（Maravai LifeSciences，MRVI）周二宣布了一项年度化5000万美元的成本削减计划，目标是到2026年实现E...
08-12 22:57
RBC Capital Maintains Outperform on Maravai LifeSciences, Lowers Price Target to $5
RBC Capital analyst Conor McNamara maintains Maravai LifeSciences (NASDAQ:MRVI) with a Outperform and lowers the price target from $7 to $5.
08-12 22:06
Maravai LifeSciences Holdings shares are trading higher. The company reported Q2 financial results.
Maravai LifeSciences Holdings shares are trading higher. The company reported Q...
08-12 04:32
Maravai LifeSciences Q2 Adj. EPS $(0.08) Misses $(0.07) Estimate, Sales $47.40M Inline
Maravai LifeSciences (NASDAQ:MRVI) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.07) by 12.68 percent. The company reported quarterly sales of $47.40 million which met
08-12 04:07
Earnings Scheduled For August 11, 2025
Companies Reporting Before The Bell • Niu Techs (NASDAQ:NIU) is expected to rep...
08-11 16:32
What to Expect from Maravai LifeSciences's Earnings
Maravai LifeSciences (NASDAQ:MRVI) will release its quarterly earnings report o...
08-09 03:07
Maravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025
Maravai LifeSciences plans to announce its Q2 2025 financial and operational results after market close on August 11, 2025. A conference call and webcast will be held that day at 2:00 p.m. PT/5:00 p.m. ET. Participants can join by dialing (800) 267-6316 or (203) 518-9783 with Conference ID MARAVAI, or via the company's website at https://investors.maravai.com. The company provides critical life science products and services for drug therapies, di...
07-28 21:08
Maravai Lifesciences appoints Rajesh Asarpota as chief financial officer
Maravai LifeSciences (NASDAQ:MRVI) announced that Rajesh Asarpota has been appointed executive vice president and chief financial officer effective June 30, 2025. He will succeed Kevin Herde, who is t...
06-26 04:08
